Granata, Simona
 Distribuzione geografica
Continente #
EU - Europa 1.522
NA - Nord America 1.503
AS - Asia 444
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 2
AF - Africa 1
OC - Oceania 1
Totale 3.476
Nazione #
US - Stati Uniti d'America 1.500
GB - Regno Unito 537
CN - Cina 341
IT - Italia 234
SE - Svezia 206
FR - Francia 157
IE - Irlanda 135
DE - Germania 94
FI - Finlandia 79
VN - Vietnam 69
UA - Ucraina 24
BE - Belgio 17
AT - Austria 9
IN - India 9
ID - Indonesia 7
RO - Romania 6
RU - Federazione Russa 6
KR - Corea 5
TR - Turchia 5
CA - Canada 3
DK - Danimarca 3
EU - Europa 3
GR - Grecia 3
CH - Svizzera 2
HU - Ungheria 2
KG - Kirghizistan 2
MY - Malesia 2
NL - Olanda 2
SG - Singapore 2
AR - Argentina 1
AU - Australia 1
BO - Bolivia 1
CZ - Repubblica Ceca 1
ES - Italia 1
HR - Croazia 1
IL - Israele 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
MD - Moldavia 1
ME - Montenegro 1
PL - Polonia 1
Totale 3.476
Città #
Southend 487
Chandler 359
Jacksonville 155
Dublin 131
Ann Arbor 108
Ashburn 99
Woodbridge 96
Beijing 72
Wilmington 54
Lawrence 50
Princeton 50
Houston 42
Dong Ket 40
Verona 38
Jinan 36
Redmond 36
New York 33
Nanjing 27
Shenyang 27
Seattle 21
Hebei 20
Helsinki 20
Sindelfingen 17
Brussels 16
Ningbo 15
Lancaster 14
Tianjin 14
Taizhou 13
Boardman 12
Changsha 11
Padova 11
Jiaxing 10
Nanchang 9
Rome 9
Vienna 9
Zhengzhou 9
Auburn Hills 8
Haikou 8
Hangzhou 8
Redwood City 8
Milan 7
Taiyuan 7
San Francisco 6
Venice 6
Washington 6
Bologna 5
Fuzhou 5
Lanzhou 5
Norwalk 5
Seoul 5
Cambridge 4
Esslingen am Neckar 4
Foggia 4
Genova 4
Guangzhou 4
Kochi 4
Turin 4
Dongguan 3
Fairfield 3
Florence 3
Los Angeles 3
Novokuznetsk 3
Parma 3
Bishkek 2
Bonndorf 2
Catania 2
Catanzaro 2
Clearwater 2
Dearborn 2
Las Vegas 2
Mehlingen 2
Messina 2
Pomezia 2
Shanghai 2
Szeged 2
Tappahannock 2
Toronto 2
Amsterdam 1
Antwerp 1
Atlanta 1
Augusta 1
Aversa 1
Bangalore 1
Bari 1
Bergamo 1
Bolzano 1
Borgo Valsugana 1
Böblingen 1
Canberra 1
Casalgrande 1
Chengdu 1
Chicago 1
Chisinau 1
Copenhagen 1
Correggio 1
Cremona 1
Crespellano 1
Crotone 1
Des Moines 1
Düsseldorf 1
Totale 2.356
Nome #
DISREGOLAZIONE DELLA BIOSINTESI E DEL METABOLISMO DEI PROTEOGLICANI/GLICOSAMINOGLICANI NEI SOGGETTI UREMICI: UNO STUDIO DI GENOMICA FUNZIONALE 161
Eparanasi: un nuovo biomarker di fibrosi e un potenziale target farmacologico per ridurre la progressione del danno renale cronico 159
IDENTIFICATION OF MOLECULAR BIOMARKERS FOR EARLY DIAGNOSIS OF DELAYED GRAFT FUNCTION IN RENAL TRANSPLANT RECIPIENTS 110
In Vitro Identification of New Transcriptomic and miRNomic Profiles Associated with Pulmonary Fibrosis Induced by High Doses Everolimus: Looking for New Pathogenetic Markers and Therapeutic Targets. 98
mTOR inhibitors and renal allograft: Yin and Yang. 97
NLRP3 Inflammasome Activation in Dialyzed Chronic Kidney Disease Patients. 90
Impact of maintenance immunosuppressive therapy on the fecal microbiome of renal transplant recipients: Comparison between an everolimus- and a standard tacrolimus-based regimen. 90
A specific immune transcriptomic profile discriminates chronic kidney disease patients in predialysis from hemodialyzed patients. 89
Proteomic-based research strategy identified laminin subunit alpha 2 as a potential urinary-specific biomarker for the medullary sponge kidney disease. 89
IDENTIFICAZIONE DI BIOMARCATORI MOLECOLARI PER LA DIAGNOSI PRECOCE DELLA FUNZIONALITÀ RITARDATA DELL'ORGANO TRAPIANTATO 88
Specific heparanase inhibition reverses glucose-induced mesothelial-to-mesenchymal transition. 88
Monoclonal antibody therapy and renal transplantation: focus on adverse effects. 86
Sirolimus and Everolimus Pathway: Reviewing Candidate Genes Influencing Their Intracellular Effects 86
Emotional symptoms, quality of life and cytokine profile in hemodialysis patients. 85
Downregulation of nuclear-encoded genes of oxidative metabolism in dialyzed chronic kidney disease patients. 84
Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial/pulmonary cells: when the dosage does matter in transplantation 84
DISTURBI PSICOLOGICI, QUALITÀ DI VITA E PRODUZIONE DI CITOCHINE NEI PAZIENTI IN EMODIALISI 81
Dialysis-related systemic microinflammation is associated with specific genomic patterns 81
Comparative transcriptome analysis of peripheral blood mononuclear cells in renal transplant recipients in everolimus- and tacrolimus-based immunosuppressive therapy 81
Transcriptomics: A Step behind the Comprehension of the Polygenic Influence on Oxidative Stress, Immune Deregulation, and Mitochondrial Dysfunction in Chronic Kidney Disease. 80
How has peritoneal dialysis changed over the last 30 years: experience of the Verona dialysis center 80
Everolimus-induced epithelial to mesenchymal transition in immortalized human renal proximal tubular epithelial cells: key role of heparanase. 78
Personalization of the Immunosuppressive Treatment in Renal Transplant Recipients: The Great Challenge in "Omics" Medicine. 78
Extra-renal adverse effects of mTOR inhibitors: know them to optimize their use in renal transplantation. 71
Dialysis-related transcriptomic profiling: The pivotal role of heparanase. 70
Mitochondria: a new therapeutic target in chronic kidney disease. 70
Sulodexide alone or in combination with low doses of everolimus inhibits the hypoxia-mediated epithelial to mesenchymal transition in human renal proximal tubular cells. 68
Heparanase regulates the M1 polarization of renal macrophages and their crosstalk with renal epithelial tubular cells after ischemia/reperfusion injury 68
Sclerostin and Dickkopf-1 in post-menopausal renal allograft recipients. 67
From pharmacogenetics to pharmacogenomics: the birth of a new era of personalized medicine in nephrology 66
Systemic and Nonrenal Adverse Effects Occurring in Renal Transplant Patients Treated with mTOR Inhibitors. 66
Sphingomyelin and medullary sponge kidney disease: a biological link identified by omics approach 65
Pharmacogenetics: a promising tool to personalize immunosuppressive therapy in renal transplantation. 65
mTOR Inhibition Role in Cellular Mechanisms 61
Naturally Occurring Compounds: New Potential Weapons against Oxidative Stress in Chronic Kidney Disease. 60
Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease 59
Proteomic Analysis of Urinary Microvesicles and Exosomes in Medullary Sponge Kidney Disease and Autosomal Dominant Polycystic Kidney Disease. 59
Pharmacogenomics: a new paradigm to personalize treatments in nephrology patients. 53
Proteomic Analysis of Urinary Extracellular Vesicles Reveals a Role for the Complement System in Medullary Sponge Kidney Disease 51
Karyopherins: potential biological elements involved in the delayed graft function in renal transplant recipients. 51
High-Dose Everolimus May Induce Pro-Inflammatory/Fibrotic Transcriptomic Changes in Bronchial Epithelial Cells from Cystic Fibrosis Patients 51
Inhibition of heparanase protects against chronic kidney dysfunction following ischemia/reperfusion injury. 45
Hypomethylation of NLRP3 gene promoter discriminates glucocorticoid-resistant from glucocorticoid-sensitive idiopathic nephrotic syndrome patients 45
PNPLA3 I148M gene variant and chronic kidney disease in type 2 diabetic patients with NAFLD: Clinical and experimental findings 42
In vitro effects of interleukin (IL)-1 beta inhibition on the epithelial-to-mesenchymal transition (EMT) of renal tubular and hepatic stellate cells. 41
Kidney Allograft Fibrosis: What We Learned From Latest Translational Research Studies 41
The Genetic Architecture of Membranous Nephropathy and Its Potential to Improve Non-Invasive Diagnosis 40
Analysis of urinary exosomes applications for rare kidney disorders. 38
Recent Advances in the Role of Natural Killer Cells in Acute Kidney Injury 30
Proteomic profile of mesothelial exosomes isolated from peritoneal dialysis effluent of children with focal segmental glomerulosclerosis 26
Totale 3.612
Categoria #
all - tutte 10.571
article - articoli 9.483
book - libri 0
conference - conferenze 1.088
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.142


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201931 0 0 0 0 0 0 0 0 0 0 15 16
2019/2020437 67 11 6 22 50 74 35 18 33 53 31 37
2020/2021446 53 86 8 37 55 34 16 19 4 6 40 88
2021/2022399 25 76 11 67 8 17 28 31 12 9 25 90
2022/20231.002 62 140 83 172 85 228 8 51 119 6 32 16
2023/2024355 23 39 49 40 57 81 9 40 3 10 4 0
Totale 3.612